Delivery Order SPE2DB22D2009-SPE2DB25FM1SZ
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Ozempic 1 mg/dose (4 mg/3 ml) 3ml vials, with a ceiling value of $23,512.44. This competitively awarded, firm fixed-price delivery order is set to conclude on July 22, 2025, and will be fulfilled from the vendor's location in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $24,818.20 on August 6, 2025, for the supply of Ozempic 2 mg/dose (8 mg/3 mL) in 3 mL vials. This is a firm fixed price, non-set-aside contract with performance completion scheduled for August 7, 2025, and fulfillment based in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a...
- The Defense Logistics Agency awarded a $5,273.97 delivery order to AmerisourceBergen Drug Corp for Ozempic 2 mg/dose (8 mg/3 mL) 3 mL vials on September 4, 2025, with an ultimate completion date of September 5, 2025. This competitively awarded, firm fixed-price contract with no set-aside utilizes a delivery order mechanism and will be performed at the contractor's Conshohocken, Pennsylvania location. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Ozempic 2 mg/dose (8 mg/3 ml) 3 ml vials, with a ceiling value of $18,294.14. This competitively awarded, firm fixed-price delivery order is set to be completed by July 31, 2025, and will be performed at the contractor's location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Ozempic 2 mg/dose (8 mg/3 mL) in 3 mL vials, with a contract ceiling value of $37,964.72. This firm fixed-price delivery order, which is non-set-aside and competitively awarded, is set to be completed by August 6, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award represents a child contract issued...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $83,604.50 on September 22, 2025, for the supply of Ozempic 2 mg/dose (8 mg/3 ml) in 3 ml vials, with completion expected by September 23, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at AmerisourceBergen's Conshohocken, Pennsylvania facility. The delivery order falls under AmerisourceBergen's broader Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, for the supply of Ozempic 1 mg/dose (4 mg/3 ml) in 3 ml vials. The competitively awarded, firm fixed-price contract has a ceiling value of $6,597.46 and an ultimate completion date of August 25, 2025. This delivery order represents a non-set-aside procurement executed through AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Ozempic 2 mg/dose (8 mg/3 mL) injectable medication with a ceiling value of $26,288.04. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of September 15, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $12,736.10 to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Ozempic 2 mg/dose (8 mg/3 mL) in 3 mL vials. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 27, 2025, with performance occurring at the contractor's facility in Conshohocken, Pennsylvania. The contract represents a child order issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $39,083.79 to AmerisourceBergen Drug Corp on September 24, 2025, for the supply of Ozempic 2 mg/dose (8 mg/3 mL) in 3 mL vials. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of September 25, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- SPE2DB22D2009Indefinite Delivery Contract
- SPE2DB22D2009-SPE2DB25FM1SZDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Ozempic 2 mg/dose (8 mg/3 ml) 3 ml vials, with a ceiling value of $89,881.88 and an ultimate completion date of September 29, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive $999,999,999.00 global pharmaceutical support vehicle valued through December 2026 that enables the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical federal medical procurement vendor supporting military and veteran healthcare systems. The company's extensive federal contract portfolio demonstrates its capability to fulfill diverse pharmaceutical supply requirements across multiple therapeutic domains, including diabetes medications, neurological treatments, pain management pharmaceuticals, antibiotics, and specialized medical supplies. Through its DLA prime contract vehicle, AmerisourceBergen serves customers including the Defense Health Agency and U.S. Coast Guard, with consistent delivery order awards featuring firm fixed pricing that range from minimal to substantial values, underscoring the company's versatility in meeting federal medical supply needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $89.9k | 9/26/25 |